Skip to main content
OpenTrials

Clinical trial condition

Stage IV Ovarian Cancer AJCC v6 and v7

Explore clinical trials studying Stage IV Ovarian Cancer AJCC v6 and v7. Study availability and eligibility vary by location and protocol.

16 public trials 1 recruiting study
Refine in advanced search Browse all conditions

Stage IV Ovarian Cancer AJCC v6 and v7 trial results

Recruiting

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

NCT05334069

Conditions
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +137 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 745 locations
View Trial Details
Completed

Pembrolizumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT02520154

Conditions
Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +24 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • MD Anderson in Katy Houston, Texas, United States
  • MD Anderson League City Nassau Bay, Texas, United States
  • MD Anderson in Sugar Land Sugar Land, Texas, United States
View Trial Details
Completed

Bevacizumab and Intravenous or Intraperitoneal Chemotherapy in Treating Patients With Stage II-III Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

NCT00951496

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine System Diseases, +55 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
View all 503 locations
View Trial Details
Completed

Talazoparib in Determining Genetic Effects on Disease Response in Patients With Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02316834

Conditions
Adnexal Diseases, Fallopian Tube Diseases, Fallopian Tube Neoplasms, +28 more
Locations
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
  • MD Anderson Regional Care Center-Katy Houston, Texas, United States
  • MD Anderson Regional Care Center-Bay Area Nassau Bay, Texas, United States
View Trial Details
Completed

Carboplatin, Paclitaxel, Bevacizumab, and Veliparib in Treating Patients With Newly Diagnosed Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00989651

Conditions
Adnexal Diseases, Brenner Tumor, Endocrine Gland Neoplasms, +59 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of Colorado Hospital Aurora, Colorado, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
View all 23 locations
View Trial Details
Completed

Veliparib and Floxuridine in Treating Patients With Metastatic Epithelial Ovarian, Primary Peritoneal Cavity, or Fallopian Tube Cancer

NCT01749397

Conditions
Stage IV Fallopian Tube Cancer AJCC v6 and v7, Stage IV Ovarian Cancer AJCC v6 and v7, Stage IV Primary Peritoneal Cancer AJCC v7
Locations
  • Mayo Clinic in Arizona Scottsdale, Arizona, United States
  • Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
  • Mayo Clinic in Rochester Rochester, Minnesota, United States
  • Siteman Cancer Center at Washington University St Louis, Missouri, United States
View Trial Details
Completed

Propranolol Hydrochloride and Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01504126

Conditions
Adnexal Diseases, Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Diseases, +44 more
Locations
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Lyndon Baines Johnson General Hospital Houston, Texas, United States
  • M D Anderson Cancer Center Houston, Texas, United States
  • The Woman's Hospital of Texas Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine With or Without Bevacizumab as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II-IV or Recurrent Stage I Epithelial Ovarian or Fallopian Tube Cancer

NCT01081262

Conditions
Adnexal Diseases, Borderline Ovarian Mucinous Tumor, Endocrine Gland Neoplasms, +38 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
  • Saint Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 248 locations
View Trial Details

Related conditions